Amanta Healthcare IPO Description – Amanta Healthcare is a pharmaceutical company specializing in sterile liquid products, including Large Volume Parenterals (LVPs) and Small Volume Parenterals (SVPs), manufactured using advanced Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technologies. As of 31 December 2024, the company operates four LVP and three SVP manufacturing lines at its WHO-GMP certified, 66,852 sq. meter facility in Hariyala, District Kheda, Gujarat.
It produces over 45 generic products across six therapeutic segments such as fluid therapy, ophthalmics, respiratory care, and irrigation solutions, offering container fill volumes from 2ml to 1000ml with diverse closure systems. The company employs 1,727 personnel, including 509 full-time staff, and maintains a dedicated Formulation & Development (F&D) and quality control lab staffed by 128 professionals.
Its international presence spans 19 countries with 47 products registered across 112 jurisdictions. Domestically, it operates through a distribution network of over 316 stockists, supported by an 108-member sales team. Amanta also partners with Indian and global pharmaceutical firms for commercial-scale manufacturing and license agreements, positioning itself as a trusted player in sterile injectable manufacturing.
Promoters of Amanta Healthcare – Bhavesh Patel, Vishal Patel, Jayshreeben Patel, Jitendrakumar Patel, and Milcent Appliances Private Limited
Table of Contents
Amanta Healthcare IPO Details
| Amanta Healthcare IPO Dates | 1 – 3 September 2025 |
| Amanta Healthcare IPO Price | INR 120 – 126 per share |
| Fresh issue | 1,00,00,000 shares (INR 120 – 126 crore) |
| Offer For Sale | Nil |
| Total IPO size | 1,00,00,000 shares (INR 120 – 126 crore) |
| Minimum bid (lot size) | 119 shares (INR 14,994) |
| Face Value | INR 10 per share |
| Retail Allocation | 35% |
| Listing On | NSE, BSE |
Amanta Healthcare Financial Performance
| FY 2023 | FY 2024 | FY 2025 | |
| Revenue | 259.13 | 280.34 | 274.71 |
| Expenses | 206.39 | 222.85 | 215.04 |
| Net income | (2.11) | 3.62 | 10.50 |
| Margin (%) | (0.81) | 1.29 | 3.82 |
Amanta Healthcare Offer News
- Amanta Healthcare RHP
- Amanta Healthcare DRHP
- ASBA IPO Forms
- Live IPO Subscription Status
- IPO Allotment Status
Amanta Healthcare Valuations & Margins
| FY 2023 | FY 2024 | FY 2025 (Pre-Issue) | FY 2025 (Post-Issue)* | |
| EPS | (0.79) | 1.35 | 3.71 | 2.70 |
| PE Ratio | – | – | 32.35 – 33.96 | 44.44 – 46.67 |
| FY 2023 | FY 2024 | FY 2025 | |
| RONW (%) | (3.36) | 5.48 | 10.89 |
| NAV | 23.44 | 24.71 | 33.43 |
| ROCE (%) | 12.19 | 12.76 | 13.72 |
| EBITDA (%) | 21.43 | 20.86 | 22.11 |
| Debt/Equity | 3.43 | 3.10 | 2.02 |
Amanta Healthcare IPO GMP Today (Daily Trend)
| Date | Day-wise IPO GMP | Kostak | Subject to Sauda |
| 8 September 2025 | 8 | – | 800 |
| 6 September 2025 | 7 | – | 700 |
| 5 September 2025 | 9 | – | 800 |
| 4 September 2025 | 9 | – | 800 |
| 3 September 2025 | 13 | – | 1,100 |
| 2 September 2025 | 27 | – | 2,500 |
| 1 September 2025 | 25 | – | 2,100 |
| 30 August 2025 | 25 | – | 2,100 |
| 29 August 2025 | 23 | – | 1,900 |
| 28 August 2025 | 23 | – | 1,900 |
| 27 August 2025 | 23 | – | 1,900 |
| 26 August 2025 | 20 | – | 1,800 |
Amanta Healthcare IPO Objectives
The company proposes to utilize the Net Proceeds from the Fresh Issue towards funding the following objects:
- Funding capital expenditure requirements for civil construction work and towards the purchase of equipment, plant and machinery for setting up a new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat – INR 70 crore
- Funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up a new manufacturing line for SVP at Hariyala, Kheda, Gujarat – INR 30.13 crore
- General corporate purposes
Amanta Healthcare IPO Subscription – Live Updates
| Category | QIB | NII | Retail | Total |
|---|---|---|---|---|
| Shares Offered | 20,00,000 | 15,00,000 | 35,00,000 | 70,00,000 |
| 3 Sep 2025 | 35.86 | 209.40 | 54.96 | 82.60 |
| 2 Sep 2025 | 0.67 | 51.58 | 27.31 | 24.90 |
| 1 Sep 2025 | 0.04 | 5.82 | 6.71 | 4.61 |
30,00,000 shares allotted to anchor investors are not included in these calculations.
Amanta Healthcare – Comparison With Listed Peers
| Company | PE ratio | EPS | RONW (%) | NAV | Revenue (Cr.) |
| Amanta Healthcare | 46.67 | 3.71 | 10.89 | 33.43 | 276.09 |
| Denis Chem Lab | 15.92 | 5.82 | 9.49 | 61.33 | 175.67 |
Amanta Healthcare IPO Allotment Status
Amanta Healthcare IPO allotment status is now on MUFG Intime’s website. Click on this link to get the allotment status.
Amanta Healthcare IPO Dates & Listing Performance
| IPO Opening Date | 1 September 2025 |
| IPO Closing Date | 3 September 2025 |
| Finalization of Basis of Allotment | 4 September 2025 |
| Initiation of refunds | 5 September 2025 |
| Transfer of shares to demat accounts | 5 September 2025 |
| Amanta Healthcare IPO Listing Date | 9 September 2025 |
| Opening Price on NSE | INR 135 per share (up 7.14%) |
| Closing Price on NSE | INR 141.75 per share (up 12.50%) |
Amanta Healthcare IPO Reviews – Subscribe or Avoid?
Angel One –
Anand Rathi –
Antique Stock Broking –
Ajcon Global –
Arihant Capital –
Axis Capital –
Ashika Research –
BP Wealth – Subscribe
Capital Market – Avoid
Canara Bank Securities –
Choice Broking –
Dalal & Broacha –
Exencial Research – Subscribe for long term
Elite Wealth – May Apply
GCL Broking –
Geojit –
GEPL Capital – Avoid
Hem Securities – Subscribe for long term
Hensex Securities –
HDFC Securities –
ICICIdirect –
IDBI Capital –
Invest4edu – Subscribe
Indsec Securities –
Jainam Broking – Subscribe for long term
KR Choksey –
LKP Research –
Marwadi Financial – Subscribe
Motilal Oswal –
Minerva Capital – Subscribe for long term
Nirmal Bang –
Reliance Securities –
Sushil Finance –
Samco Securities – Not rated
SBI Securities –
SMC Global – 1.5/5
SMIFS –
Systematix Research –
Scoope Investmart – Subscribe for long term
Ventura Securities – Subscribe
Amanta Healthcare Offer Lead Manager
BEELINE CAPITAL ADVISORS PRIVATE LIMITED
B 1311-1314, Thirteenth Floor, Shilp Corporate Park,
Rajpath Rangoli Road, Thaltej,
Ahmedabad- 380054, Gujarat, India
Phone: 079 4918 5784
Email: [email protected]
Website: www.beelinemb.com
Amanta Healthcare Offer Registrar
MUFG INTIME INDIA PRIVATE LIMITED
C-101, 1st Floor, 247 Park L.B.S. Marg,
Vikhroli West, Mumbai – 400 083, Maharashtra
Telephone: +91 810 811 4949
Email: [email protected]
Website: www.in.mpms.mufg.com
Amanta Healthcare Contact Details
AMANTA HEALTHCARE LIMITED
8th Floor, Shaligram Corporates, C.J. Marg,
Ambli, Ahmedabad – 380058, Gujarat, India
Phone: 079 67777600
Email: [email protected]
Website: www.amanta.co.in
Amanta Healthcare IPO FAQs
How many shares in Amanta Healthcare IPO are reserved for HNIs and retail investors?
The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%.
How to apply for the Amanta Healthcare Public Offer?
The best way to apply for Amanta Healthcare public offer is through Internet banking ASBA (know all about ASBA here). You can also apply online through your stockbroker using UPI. If you prefer to make paper applications, fill up an offline IPO form and deposit the same to your broker.
What is Amanta Healthcare IPO GMP today?
Amanta Healthcare IPO GMP today is INR 8 per share.
What is Amanta Healthcare’s kostak rate today?
Amanta Healthcare kostak rate today is INR NA per application.
What is the Amanta Healthcare Subject to Sauda rate today?
Amanta Healthcare Subject to Sauda rate today is INR 800 per application.